Conference
The effect of rivaroxaban exposure and clinical risk factors on efficacy and safety outcomes in patients with acute coronary syndromes
Authors
Zhang L; Yan X; Willmann S; Garmann D; Nandy P; Sharma A; Hermanowski-Vosatka A; Berkowitz SD; Spiro T; Solms A
Volume
44
Pagination
pp. S59-S59
Publisher
SPRINGER/PLENUM PUBLISHERS
Publication Date
October 1, 2017
Conference proceedings
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
ISSN
1567-567X